These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10428143)

  • 21. Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study.
    Legro RS; Kunselman AR; Stetter CM; Gnatuk CL; Estes SJ; Brindle E; Vesper HW; Botelho JC; Lee PA; Dodson WC
    J Clin Endocrinol Metab; 2017 Jan; 102(1):122-131. PubMed ID: 27778640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition.
    Kogure GS; Silva RC; Picchi Ramos FK; Miranda-Furtado CL; Lara LA; Ferriani RA; Dos Reis RM
    Gynecol Endocrinol; 2015 Mar; 31(3):237-42. PubMed ID: 25430509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lean mass and insulin resistance in women with polycystic ovary syndrome.
    Comerford KB; Almario RU; Kim K; Karakas SE
    Metabolism; 2012 Sep; 61(9):1256-60. PubMed ID: 22424820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.
    Pereira-Eshraghi CF; Chiuzan C; Zhang Y; Tao RH; McCann M; Neugut YD; Printz A; Fennoy I; Cree-Green M; Oberfield SE; Sopher AB
    Horm Res Paediatr; 2019; 92(6):365-371. PubMed ID: 32348991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.
    Baillargeon JP; Carpentier A
    Fertil Steril; 2007 Oct; 88(4):886-93. PubMed ID: 17559844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E; Canibus P; Gatti C; Frezza F; Santangelo M; Garrapa GG; Boscaro M
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
    Glintborg D; Andersen M; Hagen C; Frystyk J; Hulstrøm V; Flyvbjerg A; Hermann AP
    Eur J Endocrinol; 2006 Aug; 155(2):337-45. PubMed ID: 16868149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study.
    Kassanos D; Trakakis E; Baltas CS; Papakonstantinou O; Simeonidis G; Salamalekis G; Grammatikakis I; Basios G; Labos G; Skarantavos G; Balanika A
    Hum Reprod; 2010 Aug; 25(8):2107-14. PubMed ID: 20551072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum androgen levels and muscle mass in women with polycystic ovary syndrome.
    Douchi T; Yamamoto S; Oki T; Maruta K; Kuwahata R; Nagata Y
    Obstet Gynecol; 1999 Sep; 94(3):337-40. PubMed ID: 10472855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
    Glintborg D; Andersen M; Hagen C; Heickendorff L; Hermann AP
    J Clin Endocrinol Metab; 2008 May; 93(5):1696-701. PubMed ID: 18285411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body fat distribution in women with polycystic ovary syndrome.
    Douchi T; Ijuin H; Nakamura S; Oki T; Yamamoto S; Nagata Y
    Obstet Gynecol; 1995 Oct; 86(4 Pt 1):516-9. PubMed ID: 7675372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.
    Aydin K; Cinar N; Aksoy DY; Bozdag G; Yildiz BO
    Contraception; 2013 Mar; 87(3):358-62. PubMed ID: 22898361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.
    Fisch SC; Nikou AF; Wright EA; Phan JD; Leung KL; Grogan TR; Abbott DH; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Dec; 110(7):1367-1376. PubMed ID: 30503136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.
    González F; Minium J; Rote NS; Kirwan JP
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous adipose tissue pattern in lean and obese women with polycystic ovary syndrome.
    Tafeit E; Möller R; Rackl S; Giuliani A; Urdl W; Freytag U; Crailsheim K; Sudi K; Horejsi R
    Exp Biol Med (Maywood); 2003 Jun; 228(6):710-6. PubMed ID: 12773703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.
    Douglas CC; Norris LE; Oster RA; Darnell BE; Azziz R; Gower BA
    Fertil Steril; 2006 Aug; 86(2):411-7. PubMed ID: 16762348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.